This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Princeton University. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Rachael A Kipp: Innovator in IAP Binding Compounds
Introduction
Rachael A Kipp is a notable inventor based in Bridgewater, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that interact with cellular IAPs (inhibitor of apoptosis proteins). Her work has implications for therapeutic and diagnostic applications.
Latest Patents
Rachael A Kipp holds a patent for IAP binding compounds. These compounds are designed to bind to cellular IAPs and are mimetics of the N-terminal tetrapeptide of IAP-binding proteins, such as Smac/DIABOLO, IIid, Grim, and Reaper. The patent outlines methods for using these compounds in therapeutic, diagnostic, and assay purposes.
Career Highlights
Rachael is affiliated with Princeton University, where she continues her research and development in the field of biochemistry. Her innovative work has garnered attention and recognition within the scientific community.
Collaborations
Rachael has collaborated with esteemed colleagues, including George McLendon and Martin Case, further enhancing her research endeavors and contributions to the field.
Conclusion
Rachael A Kipp's work in developing IAP binding compounds showcases her innovative spirit and dedication to advancing biochemistry. Her contributions are paving the way for new therapeutic and diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile